EXACT Therapeutics: Global investor call regarding the ongoing warrants exercise program

06 Feb 2026 08:30 CET

Oslo, Norway, 6 February 2026. Reference is made to the stock exchange
announcement published 5 February 2026 by EXACT Therapeutics AS (the "Company",
Euronext Growth ticker: EXTX), a clinical-stage precision medicine company,
announcing that: GE Medical Holding AB (“GEMH”), a subsidiary of GE HealthCare
Technologies Inc., confirmed that it will exercise all of its 26,973,169
warrants and that remaining warrant holders therefore will have until 26
February 2026 to exercise their warrants (15 business days). Reference is also
made to the Company’s stock exchange announcement from the same day, confirming
the exercise of warrants by certain leading shareholders and primary insiders in
the Company, that together with GEMH, represent approximately 75% of the
warrants issued.

In conjunction with the ongoing warrants exercise, the Company will host a
global investor call (in English) on Wednesday, 11 February 2026 at 3 PM
CET/9:00 AM EST. The presentation will be held by the Company’s CEO, Per Walday;
CFO, John M. Edminson; and CBO, Caspar Foghsgaard.

To attend the webcast, please send an email to: ca@dnbcarnegie.no.

A copy of the company presentation will be made available in the Investors
section of the Company’s website.

About EXACT Therapeutics
EXACT Therapeutics is a clinical-stage precision medicine company utilizing the
power of ultrasound to activate the proprietary drug PS101 and enhance the
clinical benefit of oncology therapies. PS101 has a unique mode of action and
may be combined with a wide range of therapeutic agents within oncology and
across a multitude of other indications, including brain diseases. EXACT
Therapeutics’ shares are traded on Euronext Growth Oslo (EXTX). Further
information may be found here: www.exact-tx.com

For further information, please contact:
Per Walday
CEO EXACT Therapeutics
Email: per.walday@exact-tx.com

More information:
Access the news on Oslo Bors NewsWeb site